
Sign up to save your podcasts
Or


Vic and Marcus cover Jerome Powell remaining on the Federal Reserve board and concerns around Fed independence, global instability including the UAE exiting OPEC and weakening international institutions, and hyperscaler dominance with strong earnings from Google, Amazon, and Microsoft driven by AI and cloud growth; they discuss venture funding trends including brain-computer interfaces and clinical AI models, FDA adoption of AI to accelerate clinical trials, and policy shifts including the withdrawal of Casey Means’ nomination and Cigna exiting ACA markets; the episode also explores payer performance, Humana’s partnership with Mark Cuban’s Cost Plus Drugs, pharma consolidation led by Eli Lilly, and rising acquisition costs in biotech; they examine societal impacts of reduced human interaction due to technology, crypto instability and DeFi bailouts, and major AI developments including OpenAI’s slowing growth, legal challenges, China blocking Meta’s acquisition of Manus, and the accelerating gap between AI systems and human expertise in medicine
Links
Story 1: Fed Meeting
3:04 - Powell to Remain on Fed Board, Citing Legal Pressure From Trump WSJ
Story 2: OPEC
5:45 - U.A.E.’s OPEC Exit Deals Major Blow to Cartel Amid Middle East Oil Squeeze WSJ
Story 3: Cloud providers
9:35 - Google Profit Jumps 81% as Cloud Business Booms WSJ
12:49 - Amazon Posts Double-Digit Growth Anchored by Booming Web Services WSJ
13:15 - Microsoft Reports Strong Cloud Growth, but Questions About AI Returns Persist WSJ
Story 4: VC
15:54 - Axoft Raises $55M Series A to Advance Brain-Computer Interface Technology CityBiz
18:11 - Photon: $16 Million Raised To Modernize Prescription Infrastructure And Return Transparency To Patients Pulse 2.0
19:22 - Aidoc banks $150M backed by Goldman Sachs to scale clinical AI foundation model Fierce Healthcare
Story 5: FDA Looking to RWD
24:30 - FDA Turns to AI to Speed Up Clinical Trials WSJ
Story 6: Surgeon General
26:23 - Trump Withdraws Nomination of Casey Means for Surgeon General NYT
Story 7: Payors
29:54 - Cigna to exit ACA market, pursue strategic alternatives for eviCore unit Fierce Healthcare
31:01 - Centene swings to $1.5B profit as Medicaid business improves even as ACA membership falls by 2 million Fierce Healthcare
34:24 - Humana teams with Mark Cuban's Cost-Plus Drug Company Healthcare Finance
Story 8: UHS
36:13 - Universal Health Services' Q1 2026 earnings growth dampened by volume hits Fierce Healthcare
Story 9: Pharma
37:36 - Eli Lilly to Buy Ajax Therapeutics for Up to $2.3 Billion WSJ
39:06 - Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal WSJ
40:47 - There’s a Revolution in Cancer. But Can Big Pharma Afford It? WSJ
Story 10:
43:20 - We’re All Talking to Each Other Less Than We Did a Decade Ago WSJ
Story 11: Robinhood
50:00 - Robinhood Profit Rises on Boost From Prediction Markets, Gold Subscriptions WSJ
Story 12: Aave
51:48 - Crypto Rushes to Bail Out Decentralized Lender Targeted by Hackers WSJ
Story 13: AI Diagnosing Patients
56:23 - In real-world test, an AI model did better than ER doctors at diagnosing patients NPR
N/A - Performance of a large language model on the reasoning tasks of a physician Science
Story 14: OpenAI
58: 11 -OpenAI Misses Key Revenue, User Targets in High-Stakes Sprint Toward IPO WSJ
1:00:20 - OpenAI Sued by Seven Families Over Mass Shooting Suspect’s ChatGPT Use WSJ
1:01:35 - Elon Musk Testifies He Was a ‘Fool’ to Fund OpenAI WSJ
Story 15: China
1:02:41 - China Bans Meta’s Acquisition of Manus on National Security Grounds WSJ
1:03:53 -
By Marcus Whitney & Vic Gatto4.5
4141 ratings
Vic and Marcus cover Jerome Powell remaining on the Federal Reserve board and concerns around Fed independence, global instability including the UAE exiting OPEC and weakening international institutions, and hyperscaler dominance with strong earnings from Google, Amazon, and Microsoft driven by AI and cloud growth; they discuss venture funding trends including brain-computer interfaces and clinical AI models, FDA adoption of AI to accelerate clinical trials, and policy shifts including the withdrawal of Casey Means’ nomination and Cigna exiting ACA markets; the episode also explores payer performance, Humana’s partnership with Mark Cuban’s Cost Plus Drugs, pharma consolidation led by Eli Lilly, and rising acquisition costs in biotech; they examine societal impacts of reduced human interaction due to technology, crypto instability and DeFi bailouts, and major AI developments including OpenAI’s slowing growth, legal challenges, China blocking Meta’s acquisition of Manus, and the accelerating gap between AI systems and human expertise in medicine
Links
Story 1: Fed Meeting
3:04 - Powell to Remain on Fed Board, Citing Legal Pressure From Trump WSJ
Story 2: OPEC
5:45 - U.A.E.’s OPEC Exit Deals Major Blow to Cartel Amid Middle East Oil Squeeze WSJ
Story 3: Cloud providers
9:35 - Google Profit Jumps 81% as Cloud Business Booms WSJ
12:49 - Amazon Posts Double-Digit Growth Anchored by Booming Web Services WSJ
13:15 - Microsoft Reports Strong Cloud Growth, but Questions About AI Returns Persist WSJ
Story 4: VC
15:54 - Axoft Raises $55M Series A to Advance Brain-Computer Interface Technology CityBiz
18:11 - Photon: $16 Million Raised To Modernize Prescription Infrastructure And Return Transparency To Patients Pulse 2.0
19:22 - Aidoc banks $150M backed by Goldman Sachs to scale clinical AI foundation model Fierce Healthcare
Story 5: FDA Looking to RWD
24:30 - FDA Turns to AI to Speed Up Clinical Trials WSJ
Story 6: Surgeon General
26:23 - Trump Withdraws Nomination of Casey Means for Surgeon General NYT
Story 7: Payors
29:54 - Cigna to exit ACA market, pursue strategic alternatives for eviCore unit Fierce Healthcare
31:01 - Centene swings to $1.5B profit as Medicaid business improves even as ACA membership falls by 2 million Fierce Healthcare
34:24 - Humana teams with Mark Cuban's Cost-Plus Drug Company Healthcare Finance
Story 8: UHS
36:13 - Universal Health Services' Q1 2026 earnings growth dampened by volume hits Fierce Healthcare
Story 9: Pharma
37:36 - Eli Lilly to Buy Ajax Therapeutics for Up to $2.3 Billion WSJ
39:06 - Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal WSJ
40:47 - There’s a Revolution in Cancer. But Can Big Pharma Afford It? WSJ
Story 10:
43:20 - We’re All Talking to Each Other Less Than We Did a Decade Ago WSJ
Story 11: Robinhood
50:00 - Robinhood Profit Rises on Boost From Prediction Markets, Gold Subscriptions WSJ
Story 12: Aave
51:48 - Crypto Rushes to Bail Out Decentralized Lender Targeted by Hackers WSJ
Story 13: AI Diagnosing Patients
56:23 - In real-world test, an AI model did better than ER doctors at diagnosing patients NPR
N/A - Performance of a large language model on the reasoning tasks of a physician Science
Story 14: OpenAI
58: 11 -OpenAI Misses Key Revenue, User Targets in High-Stakes Sprint Toward IPO WSJ
1:00:20 - OpenAI Sued by Seven Families Over Mass Shooting Suspect’s ChatGPT Use WSJ
1:01:35 - Elon Musk Testifies He Was a ‘Fool’ to Fund OpenAI WSJ
Story 15: China
1:02:41 - China Bans Meta’s Acquisition of Manus on National Security Grounds WSJ
1:03:53 -

32,246 Listeners

30,191 Listeners

7,913 Listeners

1,105 Listeners

113,121 Listeners

56,944 Listeners

163 Listeners

27 Listeners

10,254 Listeners